Entheon Biomedical (XCNQ:ENBI) Operating Cash Flow per Share : C$-0.05 (TTM As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Operating Cash Flow per Share?

Entheon Biomedical's operating cash flow per share for the three months ended in Feb. 2024 was C$-0.02. Entheon Biomedical's operating cash flow per share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Entheon Biomedical's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:ENBI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -223.3 Med: -34.75 Max: 28.8
Current: 28.8

During the past 7 years, Entheon Biomedical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.80% per year. The lowest was -223.30% per year. And the median was -34.75% per year.

XCNQ:ENBI's 3-Year OCF Growth Rate is ranked better than
78.16% of 1236 companies
in the Biotechnology industry
Industry Median: 3.35 vs XCNQ:ENBI: 28.80

Entheon Biomedical Operating Cash Flow per Share Historical Data

The historical data trend for Entheon Biomedical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Operating Cash Flow per Share Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.53

-0.17

-1.03

-0.33

-0.06

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.03	-	-0.02	-0.01	-0.02

Competitive Comparison of Entheon Biomedical's Operating Cash Flow per Share

For the Biotechnology subindustry, Entheon Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Price-to-Operating-Cash-Flow falls into.

Entheon Biomedical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Entheon Biomedical's Operating Cash Flow per Share for the fiscal year that ended in Nov. 2023 is calculated as

Operating Cash Flow per Share (A: Nov. 2023 )	=	Cash Flow from Operations (A: Nov. 2023 )	/	Shares Outstanding (Diluted Average) (A: Nov. 2023 )
	=	-0.36	/	5.909
	=	-0.06

Entheon Biomedical's Operating Cash Flow per Share for the quarter that ended in Nov. 2023 is calculated as

Operating Cash Flow per Share (Q: Feb. 2024 )	=	Cash Flow from Operations (Q: Feb. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Feb. 2024 )
	=	-0.095	/	5.909
	=	-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05

Entheon Biomedical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Executives

Brian Jahns

Senior Officer

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines